amsacrine has been researched along with Bone Diseases, Metabolic in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amsacrine or cytarabine were administered subcutaneously in a dose of 3 mg/kg daily for four weeks." | 1.31 | [Effects of amsacrine and cytarabine on bones in rats]. ( Cegieła, U; Janiec, W, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cegieła, U | 1 |
| Janiec, W | 1 |
1 other study available for amsacrine and Bone Diseases, Metabolic
| Article | Year |
|---|---|
[Effects of amsacrine and cytarabine on bones in rats].
Topics: Amsacrine; Animals; Antineoplastic Agents; Bone and Bones; Bone Density; Bone Diseases, Metabolic; C | 2000 |